BCAX EPS Estimates
Bicara Therapeutics Inc. Common Stock
$17.34
$0.00(0.00%)
36
Overall
60
Value
27
Tech
21
Quality
Market Cap
$1.15B
Volume
1.43M
52W Range
$13.70 - $30.99
Target Price
$34.62
BCAX EPS estimates: the consensus estimate for Bicara Therapeutics Inc. Common Stock's current fiscal year is -$3.49 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BCAX EPS Estimates
- EPS estimate, current quarter
- $-0.84
- EPS estimate, next quarter
- $-0.89
- EPS estimate, current year
- $-3.49
- EPS estimate, next year
- $-3.76
- EPS growth, 3-year
- +69.43%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.52 |
| 2024 | $-4.05 |
| 2023 | $-89.61 |
| 2022 | $-88.20 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $17.34 | 0% | 1.43M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW